Targeted analyses of AD plasma such as Aβ42, Aβ40, various pTau species, GFAP and neurofilament light chain (NEFL) have provided highly informative blood-based biomarkers that clearly reflect underlying pathological processes in the brain [66]. Here, GFAP is linked to Alzheimer disease.